Basic Information
Basic information for MIR9-3HG-228-19aa-2
Peptide Name MIR9-3HG-228-19aa-2
Genome Position chr15:89395773-89395829[+]
Species Human
Peptide Sequence MAKPSEVQGQTRYSLVRGS
Peptide Length 19
Unique No (MIR9-3HG-201-19aa-4,MIR9-3HG-202-19aa-2,MIR9-3HG-203-19aa-2,MIR9-3HG-205-19aa-2,MIR9-3HG-212-19aa-3,MIR9-3HG-213-19aa-3,MIR9-3HG-214-19aa-2,MIR9-3HG-218-19aa-2,MIR9-3HG-219-19aa-2,MIR9-3HG-220-19aa-3,MIR9-3HG-221-19aa-3,MIR9-3HG-222-19aa-2,MIR9-3HG-224-19aa-2,MIR9-3HG-225-19aa-2,MIR9-3HG-226-19aa-2,MIR9-3HG-227-19aa-2,MIR9-3HG-229-19aa-2,MIR9-3HG-233-19aa-1,MIR9-3HG-240-19aa-2,MIR9-3HG-241-19aa-2,MIR9-3HG-242-19aa-2,MIR9-3HG-244-19aa-2,MIR9-3HG-246-19aa-1,MIR9-3HG-247-19aa-3,MIR9-3HG-248-19aa-2,MIR9-3HG-249-19aa-2,MIR9-3HG-251-19aa-2,MIR9-3HG-252-19aa-2,MIR9-3HG-253-19aa-1)
Grand Average of Hydropathicity -0.7526
Relative Molecular Mass 2418.68
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000662043;MIR9-3HG-228
Transcript Length 1616
Coding Ability 0.62
DNA Sequence Corresponding to Peptide ATGGCGAAACCCAGTGAGGTTCAAGGGCAAACTCGCTATTCATTAGTCAGGGGTTCT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :